Your browser doesn't support javascript.
loading
Cost-effectiveness of ceftazidime/avibactam plus metronidazole versus meropenem as first-line empiric therapy for the treatment of complicated intra-abdominal infections: A study based on the in-vitro surveillance data in China.
Shi, Xiaoping; Fu, Jie; Li, Xiaoyu; Lv, Qianzhou; Wan, Xu; Xu, Qing.
Afiliação
  • Shi X; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: shi.xiaoping@zs-hospital.sh.cn.
  • Fu J; Department of Pharmacy, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: fujieeva@163.com.
  • Li X; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: li.xiaoyu@zs-hospital.sh.cn.
  • Lv Q; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: lv.qianzhou@zs-hospital.sh.cn.
  • Wan X; Department of Pharmacy, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: wanxu2015@126.com.
  • Xu Q; Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: xu.qing@zs-hospital.sh.cn.
J Infect Public Health ; 16(3): 361-367, 2023 Mar.
Article em En | MEDLINE | ID: mdl-36689854

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ceftazidima / Infecções Intra-Abdominais Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: J Infect Public Health Assunto da revista: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ceftazidima / Infecções Intra-Abdominais Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: J Infect Public Health Assunto da revista: DOENCAS TRANSMISSIVEIS / SAUDE PUBLICA Ano de publicação: 2023 Tipo de documento: Article